Linezolid 600 mg

DRUG6 trials

Conditions

Bacterial InfectionsEarly Latent SyphilisGram-Positive Bacterial InfectionsPrimary SyphilisSecondary SyphilisSkin Diseases, BacterialStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)Thrombocytopenia; Drugs

Phase 1

A Study To Assess The Effect Of Linezolid On QTc Interval

CompletedNCT00795145

PfizerBacterial Infections

Start: 2008-12-31End: 2009-03-31Updated: 2010-06-22

Phase 2

Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

CompletedNCT03747497

MicuRxGram-Positive Bacterial Infections, Skin Diseases, Bacterial

Start: 2018-11-15End: 2019-03-26Updated: 2022-11-08

Linezolid Dosing Strategies in Drug-Resistant TB

CompletedNCT05007821

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary

Start: 2022-09-27End: 2026-01-13Updated: 2026-05-01

Phase 3

Alternative Antibiotics for Syphilis

Active, not recruitingNCT05069974

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaEarly Latent Syphilis, Primary Syphilis, Secondary Syphilis

Start: 2021-10-14End: 2026-04-30Target: 224Updated: 2025-07-22

Unknown Phase

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT

NCT05944445

Helwan UniversityThrombocytopenia; Drugs

Start: 2023-07-13End: 2024-08-31Target: 310Updated: 2023-07-17

Linezolid Plus Standard of Care

RecruitingNCT06958835

University Hospital, Basel, SwitzerlandStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Start: 2025-10-06End: 2028-10-01Target: 606Updated: 2026-03-24

Related Papers

Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial.

2026-04-20

Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial.

2024-01-0810 citations